Reliant Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Reliant Investment Management's LLY Position: Q2 2026 in Review
Reliant Investment Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $8.17K and bringing the position to 544 shares worth $652K. The position accounts for 0.23% of the portfolio, ranked #38.
Reliant Investment Management first reported a position in LLY in Q4 2017 and has held it in 27 quarters since. The position peaked at $2.91M in Q4 2017. 1,674 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Reliant Investment Management held 544 shares of Eli Lilly worth $652K as of Q2 2026.
- Reliant Investment Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
- Eli Lilly made up 0.23% of Reliant Investment Management's portfolio in Q2 2026, its #38 holding.
- Reliant Investment Management first reported a position in Eli Lilly in Q4 2017 and has held it in 27 quarters since.
- Reliant Investment Management's Eli Lilly position peaked at $2.91M in Q4 2017.
- 1,674 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Reliant Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.